About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT05005650

Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy

To evaluate the survival impact of extensive lymphadenectomy as part of debulking surgery in stage IVB ovarian cancer with supradiaphragmatic lymph node metastasis.

Lead sponsor: Seoul National University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Seoul National University Hospital

Age

18 - 90 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Histologically diagnosed ovarian, fallopian tubal, primary peritoneal cancer
•Patients suspected of metastatic lymph nodes in the cardiophrenic, internal mammary, and/or supraclavicular lymph node by CT (size larger than 5mm)
•Patients clinically diagnosed FIGO stage IVB ovarian, fallopian tubal, primary peritoneal cancer
•Patients underwent debulking surgery (primary debulking surgery or interval debulking surgery) at Seoul National University Hospital from January 2010 to January 2020
•Patients age 18-90

Exclusion Criteria

•Borderline or benign ovarian disease
•Patient didn't undergo debulking surgery
•Non-epithelial ovarian cancer

Related studies

Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy

NCT04997096 · Ovarian Cancer, Ovarian Carcinoma, and more

RECRUITINGPhase 2

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

NCT06290193 · Ovarian Cancer, Fallopian Tube Carcinoma, and more

Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients

NCT05000827 · Prostate Cancer Metastatic, Prostate Cancer, and more

Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy

NCT04744506 · Breast Cancer, Surgery, and more

RECRUITINGPhase 1

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

NCT04701645 · Ovarian Cancer, Fallopian Tube Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 26, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment121

Start dateJun 2021

Last updatedJun 26, 2023

Condition

Ovarian Cancer Stage IV Lymph Node Metastases

Locations shown

Seoul National University Hospital

Seoul, 시/도/주

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 26, 2023Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions